The Edison of Medicine

The Edison of Medicine

Author: 
Prokesch, Steven
Publisher: 
Harvard Business School Press
Date published: 
2017
Record type: 
Journal Title: 
Harvard Business Review
Source: 
Harvard Business Review, Vol. 95, No. 2, March-April 2017, pp. 134-143
Abstract: 

Early-stage research is expensive, risky, and unpredictable--so corporations generally shy away from it, leaving many opportunities unexplored. They could revitalize their research operations by adopting the approach taken by Bob Langer, a chemical engineer whose lab at MIT is one of the most productive and profitable research facilities in the world. HBR senior editor Prokesch reports in depth on Langer Lab's proven formula for accelerating the pace of discoveries and getting them into the world as products. It includes: * a focus on high-impact projects--ones that could make a major difference to society * a process for crossing the proverbial "valley of death" between research and commercial development * methods for facilitating multidisciplinary collaboration * ways to make the constant turnover of researchers and the limited duration of project funding a plus * a leadership style that balances freedom and support By drawing on the Langer Lab values and model, companies could make the world a better place and make lots of money in the process.

Language: 

CITATION: Prokesch, Steven. The Edison of Medicine . : Harvard Business School Press , 2017. Harvard Business Review, Vol. 95, No. 2, March-April 2017, pp. 134-143 - Available at: http://library.au.int/edison-medicine